Contract Manufacturing

We offer high quality contract manufacturing services to interested customers. We have a strong QC, QA and regulatory team alongwith the R&D team to support this activity.

High-end facility conforming to cGMP for manufacturing biopharmaceuticals
Quality Control facility to cater to the in-process and finished product testing
Development of analytical method and validation
Availability of experienced and competent manpower trained in GMP for manufacturing and quality systems.
Competence of R&D at all stages of development and manufacturing
High quality, cost effective and timely services
Strict adherence to the provisions of confidentiality and IPR

Vision & Mission

Biogenomics is a Science driven enterprise. Led by eminent scientists, business professionals and a focussed team of molecular biologists, microbiologists and protein engineers, Biogenomics has, in a short span of 10 years, developed dozens of Biopharmaceuticals and Biotech products.

Biogenomics has a thorough understanding of both microbial and mammalian technologies and an ability to develop own clones and cell lines. The resulting unique platform technology has allowed Biogenomics to rapidly deliver efficient, cost-effective, scalable and internationally acceptable technologies and products.

With fully integrated ‘Bench to Manufacturing’ facilities, Biogenomics ensures a quick turnaround, adaptive technology and is capable of full-scale manufacturing.

Biogenomics is consistently able to meet and exceed all regulatory standards in its products, processes and facilities.

Our proven capability to research, develop, customize and manufacture high-value biopharmaceuticals is an endorsement of our ability to meet global benchmarks. Our strengths lie in our scientific forte, proprietary technologies and state-of-the-art facilities.

Team

The Company is run by dynamic Board of Directors headed by Mr. R M Parakh, Chairman and Managing Director. Mr. Parakh is a well known and highly respected prominent NRI settled in Oman over the last 32 years. He is also the Managing Director - Finance of Saud Bahwan Group, one of largest trading house in the Gulf having annual turnover of US$ 4.5 Billion.

Biogenomics has a thorough understanding of both microbial and mammalian technologies and an ability to develop own clones and cell lines. The resulting unique platform technology has allowed Biogenomics to rapidly deliver efficient, cost-effective, scalable and internationally acceptable technologies and products.

With fully integrated ‘Bench to Manufacturing’ facilities, Biogenomics ensures a quick turnaround, adaptive technology and is capable of full-scale manufacturing.

Biogenomics is consistently able to meet and exceed all regulatory standards in its products, processes and facilities.

Our proven capability to research, develop, customize and manufacture high-value biopharmaceuticals is an endorsement of our ability to meet global benchmarks. Our strengths lie in our scientific forte, proprietary technologies and state-of-the-art facilities.

Strength

The Company is run by dynamic Board of Directors headed by Mr. R M Parakh, Chairman and Managing Director. Mr. Parakh is a well known and highly respected prominent NRI settled in Oman over the last 32 years. He is also the Managing Director - Finance of Saud Bahwan Group, one of largest trading house in the Gulf having annual turnover of US$ 4.5 Billion.

Biogenomics has a thorough understanding of both microbial and mammalian technologies and an ability to develop own clones and cell lines. The resulting unique platform technology has allowed Biogenomics to rapidly deliver efficient, cost-effective, scalable and internationally acceptable technologies and products.

With fully integrated ‘Bench to Manufacturing’ facilities, Biogenomics ensures a quick turnaround, adaptive technology and is capable of full-scale manufacturing.

Biogenomics is consistently able to meet and exceed all regulatory standards in its products, processes and facilities.

Our proven capability to research, develop, customize and manufacture high-value biopharmaceuticals is an endorsement of our ability to meet global benchmarks. Our strengths lie in our scientific forte, proprietary technologies and state-of-the-art facilities.